Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124751744 | 12475174 | 4 | F | 2016 | 20160808 | 20160617 | 20160816 | PER | US-PFIZER INC-2016295797 | PFIZER | 84.00 | YR | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124751744 | 12475174 | 1 | PS | DETROL LA | TOLTERODINE TARTRATE | 1 | 4 MG, 1X/DAY | 21228 | 4 | MG | MODIFIED-RELEASE CAPSULE, SOFT | QD | |||||||
| 124751744 | 12475174 | 2 | SS | VESICARE | SOLIFENACIN SUCCINATE | 1 | AT LOWER DOSE | Y | 0 | TABLET | |||||||||
| 124751744 | 12475174 | 3 | SS | VESICARE | SOLIFENACIN SUCCINATE | 1 | 10 MG, 1X/DAY | Y | 0 | 10 | MG | TABLET | QD | ||||||
| 124751744 | 12475174 | 4 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 124751744 | 12475174 | 5 | C | POTASSIUM | POTASSIUM | 1 | 20 MEQ, UNK | 0 | 20 | MEQ | |||||||||
| 124751744 | 12475174 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 124751744 | 12475174 | 7 | C | ELIQUIS | APIXABAN | 1 | UNK | 0 | |||||||||||
| 124751744 | 12475174 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
| 124751744 | 12475174 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 124751744 | 12475174 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 124751744 | 12475174 | 11 | C | MIRABEGRON | MIRABEGRON | 1 | UNK | 0 | |||||||||||
| 124751744 | 12475174 | 12 | C | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124751744 | 12475174 | 1 | Hypertonic bladder |
| 124751744 | 12475174 | 2 | Hypertonic bladder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124751744 | 12475174 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124751744 | 12475174 | 1 | 2014 | 0 | ||
| 124751744 | 12475174 | 2 | 2015 | 0 | ||
| 124751744 | 12475174 | 3 | 20160323 | 0 | ||
| 124751744 | 12475174 | 4 | 2013 | 0 | ||
| 124751744 | 12475174 | 5 | 2013 | 0 | ||
| 124751744 | 12475174 | 7 | 2013 | 0 | ||
| 124751744 | 12475174 | 8 | 2015 | 0 | ||
| 124751744 | 12475174 | 9 | 2014 | 0 | ||
| 124751744 | 12475174 | 10 | 2014 | 0 | ||
| 124751744 | 12475174 | 11 | 2016 | 0 |